D470-2309 Screening compound: 1-{(3S,4R)-4-[(4-ethoxyphenyl)sulfonyl]-1,1-dioxotetrahydro-1H-1lambda~6~-thiophen-3-yl}-4-piperidinecarboxamide

D470-2309 Screening compound: 1-{(3S,4R)-4-[(4-ethoxyphenyl)sulfonyl]-1,1-dioxotetrahydro-1H-1lambda~6~-thiophen-3-yl}-4-piperidinecarboxamide
D470-2309 Screening compound: 1-{(3S,4R)-4-[(4-ethoxyphenyl)sulfonyl]-1,1-dioxotetrahydro-1H-1lambda~6~-thiophen-3-yl}-4-piperidinecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound D470-2309
1-{(3S,4R)-4-[(4-ethoxyphenyl)sulfonyl]-1,1-dioxotetrahydro-1H-1lambda~6~-thiophen-3-yl}-4-piperidinecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D470-2309

Molecular Formula

C18H26N2O6S2 (C18 H26 N2 O6 S2)

Compound Name

1-{(3S,4R)-4-[(4-ethoxyphenyl)sulfonyl]-1,1-dioxotetrahydro-1H-1lambda~6~-thiophen-3-yl}-4-piperidinecarboxamide

IUPAC name

1-[(3S4R)-4-(4-ethoxybenzenesulfonyl)-11-dioxo-1lambda6-thiolan-3-yl]piperidine-4-carboxamide

SMILES

CCOc(cc1)ccc1S([C@@H](CS(C1)(=O)=O)[C@H]1N(CC1)CCC1C(N)=O)(=O)=O

InChI

InChI=1S/C18H26N2O6S2/c1-2-26-14-3-5-15(6-4-14)28(24,25)17-12-27(22,23)11-16(17)20-9-7-13(8-10-20)18(19)21/h3-6,13,16-17H,2,7-12H2,1H3,(H2,19,21)/t16-,17-/m1/s1

InChI Key

UVFLGNVRNJRZOZ-IAGOWNOFSA-N

MDL Number (MFCD)

MFCD10567746

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

430.55

Hydrogen Bond Acceptors Count

12.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

-0.206

Distribution Coefficient, logD

-0.206

Water Solubility, LogSw

-2.03

Polar Surface Area

102.110

Acid Dissociation Constant (pKa)

14.92

Base Dissociation Constant (pKb)

4.54

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

61.10

D470-2309 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Arginase Targeted Library (2009 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Male
  • Cardiovascular
Targets:
  • Others

References: we are preparing a list of scientific research reports with D470-2309 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D470-2309?
Check Price and Availability of D470-2309, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D470-2309 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D470-2309
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D470-2309
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D470-2309 available by request